312 related articles for article (PubMed ID: 9638166)
1. [Magnetic resonance in the study of suprarenal neoplasms. Qualitative and quantitative analysis of signal intensity].
Maurea S; Caracò C; Castelli L; Filice S; Alfano B; Ruffolo F; Ziviello M; Salvatore M
Radiol Med; 1998 Mar; 95(3):199-207. PubMed ID: 9638166
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
[TBL] [Abstract][Full Text] [Related]
3. [Usefulness of the modified Dixon technique associated with gadolinium administration in the characterization of adrenal masses].
Boraschi P; Braccini G; Gigoni R; Cartei F; Campatelli A; Vito AD; Perri G
Radiol Med; 1997 Mar; 93(3):218-24. PubMed ID: 9221413
[TBL] [Abstract][Full Text] [Related]
4. Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
Maurea S; Caracò C; Klain M; Mainolfi C; Salvatore M
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):188-97. PubMed ID: 15499292
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
6. [Adrenal myelolipomas: their magnetic resonance assessment].
Boraschi P; Braccini G; Gigoni R; Cartei F; Campatelli A; Di Vito A; Perri G
Clin Ter; 1996 Nov; 147(11):549-57. PubMed ID: 9264908
[TBL] [Abstract][Full Text] [Related]
7. [Role of magnetic resonance in the study of benign and malignant pheochromocytomas. Quantitative analysis of the intensity of the resonance signal].
Maurea S; Cuocolo A; Reynolds JC; Choyke PL; Keiser HR; Neumann RD; Salvatore M
Radiol Med; 1993 Jun; 85(6):803-8. PubMed ID: 8337438
[TBL] [Abstract][Full Text] [Related]
8. [Role of MR in characterizing expansive lesions of the adrenal gland].
Squillaci E; Vidiri A; Crecco M; Lo Presti G; Simonetti G
Radiol Med; 1992 Jun; 83(6):770-6. PubMed ID: 1502357
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging of thymic epithelial tumors.
Kushihashi T; Fujisawa H; Munechika H
Crit Rev Diagn Imaging; 1996 Aug; 37(3):191-259. PubMed ID: 8872410
[TBL] [Abstract][Full Text] [Related]
10. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors.
Bilbey JH; McLoughlin RF; Kurkjian PS; Wilkins GE; Chan NH; Schmidt N; Singer J
AJR Am J Roentgenol; 1995 Mar; 164(3):637-42. PubMed ID: 7863885
[TBL] [Abstract][Full Text] [Related]
11. Markedly high signal intensity lesions in the uterine cervix on T2-weighted imaging: differentiation between mucin-producing carcinomas and nabothian cysts.
Li H; Sugimura K; Okizuka H; Yoshida M; Maruyama R; Takahashi K; Miyazaki K
Radiat Med; 1999; 17(2):137-43. PubMed ID: 10399782
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging of the adrenal gland.
Boland GW; Lee MJ
Crit Rev Diagn Imaging; 1995; 36(2):115-74. PubMed ID: 7612177
[TBL] [Abstract][Full Text] [Related]
13. [Distinction between adrenal adenomas and metastases using 0.5 Telsa MR imaging: diagnosis with out-of-phase T2*-weighted gradient-field-echo image].
Ichikawa T; Fujimoto H; Uchiyama G; Murakami K; Ohtomo K
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar; 54(4):229-34. PubMed ID: 8177696
[TBL] [Abstract][Full Text] [Related]
14. Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures.
Mayo-Smith WW; Lee MJ; McNicholas MM; Hahn PF; Boland GW; Saini S
AJR Am J Roentgenol; 1995 Jul; 165(1):91-5. PubMed ID: 7785642
[TBL] [Abstract][Full Text] [Related]
15. [Role of Gadolinium-DTPA in the assessment of renal tumors with magnetic resonance].
Torricelli P; Montanari N; De Santis M; Pollastri C
Radiol Med; 1994 May; 87(5):653-61. PubMed ID: 8008898
[TBL] [Abstract][Full Text] [Related]
16. Characterization of adrenal masses using MR imaging with histopathologic correlation.
Heinz-Peer G; Hönigschnabl S; Schneider B; Niederle B; Kaserer K; Lechner G
AJR Am J Roentgenol; 1999 Jul; 173(1):15-22. PubMed ID: 10397092
[TBL] [Abstract][Full Text] [Related]
17. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
[TBL] [Abstract][Full Text] [Related]
18. [Comparative evaluation of computerized tomography/magnetic resonance (1.5 T) in the detection of brain metastasis].
Golfieri R; Cherryman GR; Olliff JF; Husband JE
Radiol Med; 1991; 82(1-2):27-34. PubMed ID: 1654578
[TBL] [Abstract][Full Text] [Related]
19. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid.
Brody JM; Schafer L; Tung GA; Breuer J; Shamsi K
J Magn Reson Imaging; 2005 Apr; 21(4):391-7. PubMed ID: 15778951
[TBL] [Abstract][Full Text] [Related]
20. Characterization of adrenal lesions using chemical shift MRI: comparison between 1.5 Tesla and two echo time pair selection at 3.0 Tesla MRI.
Nakamura S; Namimoto T; Morita K; Utsunomiya D; Oda S; Nakaura T; Hirai T; Yamashita Y
J Magn Reson Imaging; 2012 Jan; 35(1):95-102. PubMed ID: 22002867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
